The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma

Clinical Endocrinology

Volumn 66, Issue 5, 2007, Pages 703-708

  Perry, C G ^a   Sawka, A M ^b   Singh, R ^c   Thabane, L ^d,e   Bajnarek, J ^f   Young Jr , W F ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MAYO CLINIC   (United States)

^d CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

METADRENALIN; NORMETADRENALIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METANEPHRINE; MIDDLE AGED; NORMETANEPHRINE; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 34247869667     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02805.x     Document Type: Article

References (20)

1. Lenders, J.W.M., Eisenhofer, G., Mannelli. M. Pacak, K. (2005) Phaeochromocytoma. Lancet, 266, 665 675.
2. Young, W.F. Maddox, D.E. (1995) Spells: in search of a cause. Mayo Clinic Proceedings, 70, 757 765.
3. Bryant, J., Farmer, J., Kessler, L.J., Townsend, R.R. Nathanson, K.L. (2003) Pheochromocytoma: the expanding genetic differential diagnosis. Journal of the National Cancer Institute, 95, 1196 1204.
4. Neumann, H.P., Bausch, B., McWhinney, S.R., Bender, B.U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., Januszewicz, A., Eng, C., Smith, W.M., Munk, R., Manz, T., Glaesker, S., Apel, T.W., Treier, M., Reineke, M., Walz, M.K., Hoang-Vu, C., Brauckhoff, M., Klein-Franke, A., Klose, P., Schmidt, H., Maier-Woelfle, M., Peczkowska, M., Szmigielski, C. Freiburg-Warsaw-Columbus Pheochromocytoma Study Group (2002) Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine, 346, 1459 1466.
5. Kudva, Y.C., Young, W.F. Thompson, G.B., Grant, C.S. van Heerden, J.A. (1999) Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist, 9, 77 80.
6. Lenders, J.W., Pacak, K., Walther, M.M., Linehan, W.M., Mannelli, M., Friberg, P., Keiser, H.R., Goldstein, D.S. Eisenhofer, G. (2002) Biochemical diagnosis of pheochromocytoma: which is the best test? Journal of the American Medical Association, 287, 1427 1434.
7. Pisano, J.J. (1960) A simple analysis for normetanephrine and metanephrine in the urine. Clinica Chimica Acta, 5, 406 414.
8. Kudva, Y.C., Sawka, A.M. Young, W.F. Jr (2003) Clinical review 164: the laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. Journal of Clinical Endocrinology and Metabolism, 88, 4533 4539.
9. Sawka, M.A., Jaeschke, R., Singh, R.J. Young, W.F. Jr (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. Journal of Clinical Endocrinology and Metabolism, 88, 553 558.
10. Sawka, A.M., Prebtani, A.P., Thabane, L., Gafni, A., Levine, M. Young, W.F. Jr (2004) A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocrine Disorders, 4, 2.
11. Lenders, J.W.M., Eisenhofer, G., Armando, I., Keiser, H.R., Goldstein, D.S. Kopin, I. (1993) Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clinical Chemistry, 39, 97 103.
12. Eisenhofer, G. (2003) Biochemical diagnosis of pheochromocytoma. Is it time to switch to plasma-free metanephrines? Journal of Clinical Endocrinology and Metabolism, 88, 550 552.
13. Eisenhofer, G., Goldstein, D.S., Walther, M.M., Friberg, P., Lenders, J.W.M., Keiser, H.R. Pacak, K. (2003) Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. Journal of Clinical Endocrinology and Metabolism, 88, 2656 2666.
14. Young, W.F. Jr (1993) Pheochromocytoma: 1926-1993. Trends in Endocrinology and Metabolism, 4, 122 127.
15. Davidson, F.D. (2004) Paracetamol-associated interference in an HPLC-ECD assay for urinary free metadrenalines and catecholamines. Annals of Clinical Biochemistry, 41, 316 320.
16. Lax, P., Ruthven, C.R. Sandler, M. (1979) Labetalol and urinary metadrenalines. British Medical Journal, 1, 953.
17. Taylor, R.L. Singh, R.J. (2002) Validation of liquid chromatography- tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. Clinical Chemistry, 48, 533 539.
18. Altman, D.G., Machin, D., Bryant, T.N. Gardner, M.J. (2000) Statistics with Confidence, 2nd edn. BMJ Books, London, UK, 104 110.
19. Hanley, J.A. McNeil, B.J. (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29 36.
20. Schisterman, E.F., Faraggi, D. Reiser, B. (2004) Adjusting the generalized ROC curve for covariates. Statistics in Medicine, 23, 3319 3331.